Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Table S36. Canonical signaling pathways populated by extracted phosphoproteins unique to non-stimulated or MeCh-stimulated CMP-state SH-SY5Y cells. Significantly populated canonical signaling pathways, unique to a specific stimulation condition (nonstimulated or with a specific MeCh dose) are listed. Canonical signaling pathways were considered enriched only if at least two proteins were present in each signaling pathway and with a probability of ≤0.05. Hybrid signaling pathway scores indicated were generated by multiplication of the pathway enrichment ratio with the negative log10 of the probability result. Canonical signaling pathway Hybrid 10nM MeCh 100nM MeCh Endothelin-1 Signaling Role of BRCA1 in DNA Damage Response Synaptic Long Term Depression Thrombin Signaling Cellular Effects of Sildenafil (Viagra) Mitotic Roles of Polo-Like Kinase 18.6 14.7 13.6 10.5 7.86 5.72 1μM MeCh Bladder Cancer Signaling Neuregulin Signaling Glycine, Serine and Threonine Metabolism Leukocyte Extravasation Signaling 6.64 6.49 3.24 2.84 10μM MeCh Systemic Lupus Erythematosus Signaling Thrombopoietin Signaling iCOS-iCOSL Signaling in T Helper Cells IL-4 Signaling Renal Cell Carcinoma Signaling IL-3 Signaling Ceramide Signaling April Mediated Signaling B Cell Activating Factor Signaling IGF-1 Signaling HMGB1 Signaling EGF Signaling Neuropathic Pain Signaling In Dorsal Horn Neurons T Cell Receptor Signaling Endometrial Cancer Signaling IL-2 Signaling CD28 Signaling in T Helper Cells Angiopoietin Signaling CD40 Signaling Erythropoietin Signaling Neurotrophin/TRK Signaling Relaxin Signaling FLT3 Signaling in Hematopoietic Progenitor Cells Sphingolipid Metabolism IL-17 Signaling 16.1 15.2 14.5 13.4 12.6 12.4 11.8 11.1 10.7 10.1 9.76 9.48 9.05 9.05 8.6 8.47 8.06 7.4 7.4 7.09 7.09 6.93 6.8 6.61 6.52 LPS-stimulated MAPK Signaling PDGF Signaling Prolactin Signaling Chemokine Signaling BMP signaling pathway Aminoacyl-tRNA Biosynthesis Regulation of Actin-based Motility by Rho Factors Promoting Cardiogenesis in Vertebrates Prostate Cancer Signaling FAK Signaling Starch and Sucrose Metabolism Melanocyte Development and Pigmentation Signaling Linoleic Acid Metabolism Amyotrophic Lateral Sclerosis Signaling IL-6 Signaling SAPK/JNK Signaling Chronic Myeloid Leukemia Signaling Role of NFAT in Regulation of the Immune Response HGF Signaling Sphingosine-1-phosphate Signaling Natural Killer Cell Signaling fMLP Signaling in Neutrophils IL-12 Signaling and Production in Macrophages Histidine Metabolism Actin Cytoskeleton Signaling G-Protein Coupled Receptor Signaling Huntington's Disease Signaling Arachidonic Acid Metabolism Hepatic Cholestasis mTOR Signaling Cardiac Hypertrophy Signaling Eicosanoid Signaling Dendritic Cell Maturation cAMP-mediated Signaling 6.52 6.52 6.52 6.34 6.26 6.16 5.85 5.77 5.77 5.55 5.55 5.48 5.27 5.2 5.14 5.07 4.82 4.72 4.59 4.42 4.31 4.16 4.11 3.78 3.39 3.39 3.29 3.25 3.1 2.99 2.82 2.75 2.44 2.36 100μM MeCh Aminosugars Metabolism Lysine Degradation ß-alanine Metabolism Propanoate Metabolism Pantothenate and CoA Biosynthesis Valine, Leucine and Isoleucine Degradation VDR/RXR Activation O-Glycan Biosynthesis PPARa/RXRa Activation Fatty Acid Metabolism 13.1 8.96 7.83 7.11 6.57 6.3 5.44 5.2 3.86 2.75